Neurocare names Tariq El-Titi as senior vice president for MENA

He held leadership roles at Dubai Healthcare City, Mubadala Healthcare's Cleveland Clinic Abu Dhabi, and Proximie.

Neurocare Group AG has appointed Tariq El-Titi as the senior vice president (SVP) for the Middle East and North Africa (MENA) region.

Before his appointment, El-Titi held leadership positions at Dubai Healthcare City, Mubadala Healthcare's Cleveland Clinic Abu Dhabi, and Proximie.

He founded Janus Ventures in 2018 and has a portfolio of venture investments across the United Arab Emirates, Saudi Arabia, and the UK.

ALSO READ: Australia’s upcoming Footscray Hospital advances with completed exterior

"We warmly welcome Tariq to the Neurocare team," Thomas Mechtersheimer, CEO of Neurocare Group AG, said.

“With Tariq's expertise, we are poised to expand our footprint in the MENA region, furthering our mission of innovating personalised mental health treatments and creating a positive health impact within the region,” Mechtersheimer added.

Also Read

Tech strips the scare off spine surgeries

Fakeeh Care Group announces final IPO price of $15.3 per share

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit

Top News

Fakeeh Care Group announces final IPO price of $15.3 per share

Subscription period is on 21 and 22 May.

Healthcare

2 days ago

Burjeel Medical City partners with TII for cancer treatment

The two-year collaboration will focus on engineering T-cell-based therapeutics and TIL therapy.

Healthcare

2 days ago

APAC’s prosthetic heart valve market to record 11.9% CAGR until 2035

The global market is expected to reach $30.3b within the forecast period.

Healthcare

2 days ago

Peripheral artery disease market poised for $10.8b growth by 2035

APAC expects notable CAGR growth within the forecast period.

Healthcare

2 days ago

Exclusives

MakatiMed advances towards precise surgical care with Da Vinci Xi robotic system

The tech allows for minimally invasive techniques in urology, hepatobiliary, cardiovascular, thoracic, obstetrics and gynaecology, and general surgery.

Healthcare

5 days ago

The Medical City paves the way for AI-integrated local healthcare and research with Lunit